Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Stephen Sanche

Showing results (11-20 of 22) with videos related to

Pageof 3
Sort By:
Clinical Proteomics|August 3, 2023
Identification of SARS-CoV-2 biomarkers in saliva by transcriptomic and proteomics analysisLina M Marin, George S Katselis, Paulos Chumala, et al.
Journal of Chemotherapy (Florence, Italy)|June 16, 2020
Bacteremia with <i>Staphylococcus pseudintermedius</i> in a 4 month old pediatric oncology patientLeah D Blondeau, Joseph E Rubin, Harry Deneer, et al.
Journal of Chemotherapy (Florence, Italy)|February 1, 2021
Recovery of borderline oxacillin-resistant <i>Staphylococcus pseudintermedius</i> (BORSP) from bone and soft tissue of a rheumatoid arthritis patient with severe osteoporosis: transmission from the family dogLeah D Blondeau, Stephen Sanche, David J Sauder, et al.
Nuclear Medicine and Biology|March 1, 2020
Comparison of various radioactive payloads for a human monoclonal antibody to glycoprotein 41 for elimination of HIV-infected cellsRavendra Garg, Kienna Mills, Kevin J H Allen, et al.
Journal of Neurosurgery. Case Lessons|August 4, 2023
Pediatric intracranial tuberculoma: illustrative caseEva Liu, Pramath Kakodkar, Henry Pan, et al.
AIDS (London, England)|July 27, 2018
Extensive host immune adaptation in a concentrated North American HIV epidemicZabrina L Brumme, Natalie N Kinloch, Stephen Sanche, et al.
Human Vaccines & Immunotherapeutics|June 10, 2026
Safety and immunogenicity of a booster dose of COVAC-2, a Sepivac SWE™ adjuvanted SARS-CoV-2 recombinant protein vaccine in previously vaccinated healthy adults; a randomized controlled multicentre trialGlenn Hamonic, Supriya Arora, Ravendra Garg, et al.
AIDS (London, England)|November 20, 2025
Antiretroviral utilization and adherence before versus after expansion of a provincial drug insurance policyAnn M Babu, Donica Janzen, Charity D Evans, et al.
The Canadian Journal of Hospital Pharmacy|October 17, 2022
Trends in Use of Combination Antiretroviral Therapy and Treatment Response from 2000 to 2016 in the Canadian Observational Cohort (CANOC): A Longitudinal Cohort StudyAlison R McClean, Jason Trigg, Claudette Cardinal, et al.
BMC Infectious Diseases|November 23, 2019
Characteristics and outcomes of antiretroviral-treated HIV-HBV co-infected patients in Canada?Urvi Rana, Matt Driedger, Paul Sereda, et al.
Pageof 3

Showing results (11-20 of 22) with videos related to

Sort By:
Pageof 3
Clinical Proteomics|August 3, 2023
Identification of SARS-CoV-2 biomarkers in saliva by transcriptomic and proteomics analysisLina M Marin, George S Katselis, Paulos Chumala, et al.
Journal of Chemotherapy (Florence, Italy)|June 16, 2020
Bacteremia with <i>Staphylococcus pseudintermedius</i> in a 4 month old pediatric oncology patientLeah D Blondeau, Joseph E Rubin, Harry Deneer, et al.
Journal of Chemotherapy (Florence, Italy)|February 1, 2021
Recovery of borderline oxacillin-resistant <i>Staphylococcus pseudintermedius</i> (BORSP) from bone and soft tissue of a rheumatoid arthritis patient with severe osteoporosis: transmission from the family dogLeah D Blondeau, Stephen Sanche, David J Sauder, et al.
Nuclear Medicine and Biology|March 1, 2020
Comparison of various radioactive payloads for a human monoclonal antibody to glycoprotein 41 for elimination of HIV-infected cellsRavendra Garg, Kienna Mills, Kevin J H Allen, et al.
Journal of Neurosurgery. Case Lessons|August 4, 2023
Pediatric intracranial tuberculoma: illustrative caseEva Liu, Pramath Kakodkar, Henry Pan, et al.
AIDS (London, England)|July 27, 2018
Extensive host immune adaptation in a concentrated North American HIV epidemicZabrina L Brumme, Natalie N Kinloch, Stephen Sanche, et al.
Human Vaccines & Immunotherapeutics|June 10, 2026
Safety and immunogenicity of a booster dose of COVAC-2, a Sepivac SWE™ adjuvanted SARS-CoV-2 recombinant protein vaccine in previously vaccinated healthy adults; a randomized controlled multicentre trialGlenn Hamonic, Supriya Arora, Ravendra Garg, et al.
AIDS (London, England)|November 20, 2025
Antiretroviral utilization and adherence before versus after expansion of a provincial drug insurance policyAnn M Babu, Donica Janzen, Charity D Evans, et al.
The Canadian Journal of Hospital Pharmacy|October 17, 2022
Trends in Use of Combination Antiretroviral Therapy and Treatment Response from 2000 to 2016 in the Canadian Observational Cohort (CANOC): A Longitudinal Cohort StudyAlison R McClean, Jason Trigg, Claudette Cardinal, et al.
BMC Infectious Diseases|November 23, 2019
Characteristics and outcomes of antiretroviral-treated HIV-HBV co-infected patients in Canada?Urvi Rana, Matt Driedger, Paul Sereda, et al.
Pageof 3